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Abstract 
Platelet adhesion to the sub-endothelial matrix and damaged endothelium occurs through a 
multi-step process mediated in the initial phase by glycoprotein Ib binding to von Willebrand 
factor, which leads to the subsequent formation of a platelet plug. The plant-derived omega-3 
fatty acid alpha-linolenic acid is an abundant alternative to fish-derived n-3 FA and has anti-
inflammatory and anti-thrombotic properties. In this study, we investigated the impact of 
alpha-linolenic acid on human platelet binding to vWF under high-shear flow conditions 
(mimicking blood flow in stenosed arteries). Pre-incubation of fresh human blood from 
healthy donors with alpha-linolenic acid at dietary relevant concentrations reduced platelet 
binding and rolling on vWF-coated microchannels at a shear rate of 100 dyn/cm2. Depletion 
of membrane cholesterol by incubation of platelet-rich-plasma with methyl-beta cyclodextrin 
abrogated platelet rolling on vWF. Analysis of glycoprotein Ib by applying cryo-electron 
tomography to intact platelets revealed local clusters of glycoprotein Ib complexes, upon 
shear-force exposure, whose formation could be prevented by alpha-linolenic acid treatment. 
This study provides novel findings on the rapid local rearrangement of the  glycoprotein Ib 
complexes in response to high-shear flow and highlights the mechanism of in vitro inhibition 
of platelet binding to and rolling on vWF by alpha-linolenic acid.  
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Introduction 
The first event leading to the formation of a platelet plug is mediated by the glycoprotein Ib-
IX complex (GpIb-IX), the second most-abundant platelet receptor after the integrin αIIbβ31–
3
. Platelet binding to von Willebrand factor (vWF) is tightly controlled in order to occur only 
at sites of bleeding but not in the normal circulation, where it would cause thrombosis. This 
regulation involves activation of vWF only at high flow rates and binding of GpIb to the A1 
domain of vWF through a 2-step mechanism, where vWF multimer first elongates, then the 
A1 domain transitions to a high-affinity state4–6. The role of high-shear flow in the 
pathogenesis of thrombosis is particularly relevant under pathological conditions such as in 
stenosed, atherosclerotic arteries, where shear stress can increase above 100 dyn/cm2 (shear 
rate > 4000/sec)7,8. Because of its pivotal role in initiating platelet adhesion, GpIb represents 
a promising anti-thrombotic target.  
Omega-3 fatty acids (n-3 FA) are a class of naturally occurring polyunsaturated fatty acids; 
the plant-derived alpha-linolenic acid (ALA), whose cardioprotective effects have been 
shown by us and others9–12, is readily available, whereas limited fishery resources and sea 
pollution restrict the use of marine-derived n-3 FA13–15. N-3 FA modulate cellular responses 
through incorporation into plasma membranes and reduction in the formation of typical 
protein complexes/lipid rafts, among other effects16–18. Based on our previous observations 
that ALA reduces platelet reactivity10,19, and on studies showing the presence of GpIb in lipid 
rafts20–22, we hypothesized that ALA might interfere with GpIb distribution on the plasma 
membrane in high-shear flow and, therefore, binding to vWF.  
Methods 
Blood samples 
Blood from healthy volunteers was obtained from the Blood Center of the Swiss Red Cross at 
the Cantonal Hospital Baden with informed consent according to the declaration of Helsinki. 
The study was approved by the Institutional Review Board. EDTA or citrated blood was kept 
at room temperature until assays performed (within 2 hours of drawing). Blood was 
incubated with vehicle (0.1% ethanol) or ALA 30 μM for 1 hour at room temperature before 
being used for subsequent experiments. The n-3 FA dose was chosen based on a previous 
study showing this to be a dietary reachable concentration23 . Platelet adhesion to vWF was 
performed on a Bioflux 200 system (Fluxion Bioscience, San Francisco, US) according to the 
manufacturer’s protocol (see Supplementary Data file for details).  
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Immunofluorescence staining for Ground State Depletion (GSD) microscopy  
Washed platelets isolated from vehicle or ALA-treated samples were fixed with 4% PFA for 
15 minutes, then spun on a 1.5 coverslip in a Cytospin (Thermo Fisher Scientific, Waltham, 
US) and stained for GSD microscopy. For details, see the Supplementary Data file. 
Flow cytometric analysis of vWF binding 
Platelet-rich plasma (PRP) or washed platelets from vehicle or ALA-treated blood samples 
were fixed with 4%PFA for 15 minutes, followed by incubation in 1%BSA in PBS 
containing a rabbit anti-human vWF antibody (1:500, Dako A0082) and an anti-GpIbα-APC 
(BD Bioscience, San Jose, US) for 1 hour. In some experiments, exogenous human vWF 
(100 ug/ml, Hematologic Technologies) was added to washed platelets. Samples were 
washed 3x in 1% BSA in PBS and then stained with an anti-rabbit 488 (1:250, Jackson 
Immunoresearch, West Grove, PA, USA) for 30 minutes. After 3 washes in 1% BSA in PBS, 
samples were resuspended in 300 μl PBS and analyzed on a LSR Fortessa (BD Bioscience, 
San Jose, US).  
Cryo-electron tomography 
Resting and sheared platelets in Tyrode’s buffer were seeded on gold grids coated with a 
Silicon mesh (R 1/4, 200 mesh, Quantifoil, Jena, Germany). Platelets were allowed to adhere 
for 10 min and then fixed with 4% formaldehyde for 5 min at room temperature, before being 
processed for cryo-electron tomography. Receptor detection was achieved for GpIb and 
integrin αIIbβ3 with immunogold labeling (details are given in the Supplementary Data). 
Data acquisition was performed using an FEI Titan Krios. Tomograms were acquired with a 
magnification of 42,000× corresponding to a pixel size of 0.34nm. The receptors density 
was analyzed using MATLAB scripts and the receptors distributions were plotted and 
statistically analyzed by the OriginLab software (Northampton, Massachusetts, USA). 
Statistical analysis 
Data are plotted as mean ±SEM of at least three independent experiments. They were 
analysed by paired, two-tailed Student’s t-test with GraphPad Prism version 7 (GraphPad 
Software, La Jolla, US). P values <0.05 were considered significant. 
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Results 
Pre-incubation of blood with the n-3 FA ALA at dietary relevant concentrations23 reduced 
GpIb/vWF interaction under pathological high-shear flow (10’000 s-1, corresponding to an 
80% stenosed artery), as measured by the platelet-covered area (106’963 ±15’892 µm2 
vehicle vs 75’519 ±16’254 µm2 ALA, Figure 1A-B and Supplemental Video 1 and 2). 
Analysis of single fluorescently labelled platelets showed that their speed was doubled when 
pre-incubated with ALA (Figure 1C), while the distance travelled before stopping was 
increased (8.89 ±4.0 µm vehicle vs 13.36 ±7.2 µm ALA, Figure 1D and E).  
It has been reported that GpIb resides in cholesterol-rich membrane domains termed lipid 
rafts20,21,24,25, and that it appears to cluster in high-shear flow conditions22. In agreement with 
these findings, cholesterol depletion with methyl-beta-cyclodextrin (MβCD), able to remove 
50-90% of membrane cholesterol26, greatly reduced platelet adhesions to vWF, 
demonstrating the pivotal role of membrane cholesterol in GpIb-vWF adhesion under high-
shear flow (188±16 µm2, Figure 1F).  
To exclude that the reduced adhesion of ALA-treated platelets was due to lower levels of 
membrane GpIb, vehicle and ALA-treated washed platelets were exposed to high-shear flow 
in a viscometer (10’000 s-1, 1 minute) and analysed by flow cytometry. Levels of membrane 
GpIb were not different between vehicle and ALA-treated platelets (Figure 2A); rather, pre-
treatment with the n-3 FA preserved GpIb levels, as shown by higher fluorescence values, 
suggesting it had an inhibitory effect on GpIb cleavage, as previously shown by our group19.  
Next, we analysed whether the effect on GpIb-vWF binding was specific for GpIb, vWF, or 
both. Whole blood was pre-treated with ALA or vehicle for 1 hour, followed by isolation of 
platelet-rich plasma (PRP) and exposure to high-shear flow (10’000 s-1, 1 minute). Flow 
cytometric analysis of platelet-bound vWF showed that pathological high-shear flow was 
able to induce GpIb-vWF binding, and that this was not influenced by the presence of ALA 
(Figure 2B). When the same experiment was performed with washed platelets, we could not 
detect any platelet-bound vWF, demonstrating the plasmatic origin of the bound vWF (Figure 
2C); however, addition of exogenous human vWF to washed platelets was able to restore 
vWF-platelet binding (Figure 2C). These results show that ALA has no effect on vWF itself, 
and suggest that its inhibitory effect is exerted through platelet GpIb and is specific for 
binding to anchored vWF (as typically exposed in vivo from endothelial cells after injury).  
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High resolution imaging of the GpIb receptors at the plasma membrane of intact platelets was 
conducted using cryo-electron tomography27 (cryo-ET, Figure 3 A-C). Adherent platelets 
were incubated with anti-GpIb antibodies decorated with 6-nm gold-protein A and imaged 
with cryo-ET. The coordinates of the gold nanoclusters were identified (Figure 3 A-C). While 
the overall number of receptors per platelet is not significantly varied (115 ±50 per µm2 for 
the adherent platelets and 130 ±50 per µm2 in the case of the sheared activated platelets), the 
distribution of receptors varied. To quantify these changes, we analysed the clustering 
properties of GpIbα by calculating, for each receptor, the number of receptors within a 50 nm 
radius. Figure 3 E-G shows normal distributions of neighbourhood receptors, with an average 
of 2.5 ± 1.8 neighbours for the adherent platelets, 3 ± 2.3 neighbours for the shear activated 
platelets and 3 ± 1.8 in the case of the ALA treated platelets. While the global distribution of 
receptors remains similar, 9% of the receptors have ≥12 neighbours in the shear activated 
platelets (41/453, Figure 3F), while in the case of platelets treated with ALA only 3.8% of 
receptors have more than 12 neighbours (14/366, Figure 3G). As a control, we have analysed 
the density and number of neighbours of the platelet integrin αIIbβ3. This analysis showed a 
much higher density of the integrin receptors (450 ± 180 per μm2) and with many neighbours 
in comparison to the GpIb receptors (10 ± 5, Figure 3 D and H, and Supplementary Figure 3), 
which is in agreement with the difference in abundance of the two receptors in platelets28.  
Analysis of immunofluorescent-stained GpIbα by GSD super-resolution microscopy also 
revealed that GpIb is abundantly expressed over the whole platelet membrane with small 
local points of high density (Figure 4A). To compare between the GSD microscopy and cryo-
ET we have adopted a recently developed strategy29. We used an assembly of the cryo-ET 
data into a 5 µm x 5 µm collage, where the coordinates of the 6 nm gold labeled GpIb were 
drawn as red dots and blurred to 20 nm resolution to match the GSD data (Figure 4B). The 
obtained synthetic model of platelet perimeter shows a distribution and appearance of the 
receptor in agreement with the fluorescence data, with high density of GpIb throughout the 
membrane, but, interestingly, also local, small regions of more densely packed complexes 
(Figure 4B, arrowhead). Blood pre-treatment with ALA did not show a change in the 
distribution of membrane GpIb by total internal reflection fluorescence (TIRF), likely due to 
the small size of GpIb clusters, which is in the same range of the resolution of the technique 
(Figure 5). 
Stivala et al. GpIb clustering in shear-activated platelets 7 
Discussion 
α-Linolenic acid is a plant-derived n-3 FA readily available in certain plant oils such as 
flaxseed, soybean and canola oil. Epidemiological studies have shown an inverse correlation 
between dietary ALA and cardiovascular events11,30,31, although the molecular mechanisms of 
this protection are not completely known. Our group has investigated the molecular basis of 
several cardio-protective effects of ALA, showing that at least some of its effects are 
mediated by its action on endothelial cells, leukocytes and platelets9,10,19. In this study, we 
have focused in particular on platelet adhesion to vWF under high-shear conditions, which 
represents the first step mediating platelet activation under arterial flow and is especially 
important in stenosed (atherosclerotic) arteries, where shear can reach extremely high values 
(>5’000 s-1)7,32,33.  
Here we show for the first time that ALA is able to partially inhibit platelet adhesion to vWF 
under a shear flow of 10’000 s-1, when whole blood is pre-incubated for 1 hour with ALA at 
dietary relevant concentrations23. This is accompanied by an increase in speed and distance 
traveled by ALA-treated platelets, compared to vehicle treatment (Figure 1), and extends 
previous results from our group showing a reduced aggregation of citrate platelets over 
collagen at low shear19 . The effect observed is specific to anchored vWF, since vWF binding 
upon exposure of platelet-rich plasm to high-shear flow could not be altered by ALA pre-
treatment (Figure 2). A similar inhibition of platelet adhesion is obtained with the longer, 
marine-derived n-3 FA eicosapentaenoic acid (EPA), while the saturated fatty acid stearic 
acid had no effect (Supplementary Figure 4). Although the inhibitory effect of ALA may 
seem small (25% reduction in platelet adhesion), its biological implications are important, 
since inhibition at this early step will reduce the number of platelets activated in response to 
GpIb engagement and subsequent signaling leading to thrombus formation. The additional 
inhibitory effects of ALA at the level of intracellular signaling and granule secretion will 
lead, overall, to a greater effect with a relevant biological significance on atherothrombosis. 
Since platelet binding to vWF is mediated by the GpIb receptor, we employed state-of-the-art 
methods (superresolution microscopy by GSD and cryo-electron tomography) to analyze 
GpIb distribution on the platelet membrane at high-resolution. 
The GpIb distribution analysis by cryo-ET suggests that a significant subpopulation of 
receptors clustered into a high number of neighbours in the shear activated (and to a lesser 
extent in the ALA-treated) platelets, indicating that platelet exposure to shear stress induces a 
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local rearrangement of GpIb at the platelet plasma membrane, forming discrete small regions 
of high receptor density (Figure 3). These regions presumably represent high affinity 
“binding units” or even binding loci for anchoring of multimeric vWF.  
Our observations are in line with previous findings34 showing that under high-shear stress 
platelets form local points of adhesion, termed “discrete adhesion points” (DAPs), and 
describing DAPs as the putative regions of interaction between platelets/vWF. Our functional 
and structural data provides a high-resolution insight into the position of the GpIb receptors 
and supports a model where high-shear stress induces a rapid, local rearrangement of GpIb 
receptors into small “clusters” of 15-20 complexes. This subpopulation of receptors may 
represent the previously described high-affinity binding units that interact with vWF and 
enable platelet rolling under arterial flow. Pre-incubation of platelets with ALA reduces the 
local clustering of GpIb receptors as shown by the virtual absence of larger complexes (GPIb 
with ≥17 neighbors, Figure 3C and G). On the functional side, this provides an explanation as 
to why adhesion is significantly inhibited by ALA pre-treatment while platelet rolling speed 
is increased (Figure 1A and C). Previous work has shown that omega-3 (of marine origin) 
can inhibit protein palmitoylation and, therefore, localization to lipid rafts35. Although in our 
settings we have used a pre-incubation time too short to achieve an analogue effect, long-
term, nutritional supplementation with ALA may also inhibit GpIb localization to lipid rafts 
via a reduced palmitoylation and, consequently, reduce platelet adhesion to vWF even more  
through this additional mechanism. 
Taken together, these data provide insight into the possible mechanism of the anti-thrombotic 
properties of n-3 FA in the early phase of thrombosis at sites of arterial stenosis or plaque. It 
may therefore represent the basis for a therapeutic approach which interferes with this 
process.  
In conclusion, our structural data from intact platelets, including cryo-ET and super-
resolution microscopy, show that upon high-shear conditions platelet GpIb receptors 
reorganize into “clusters” of 10 to 20 complexes closer to each other than on resting platelets; 
functionally, we demonstrate that - by the intervention with the plant-derived n-3 FA ALA - 
the size of these clusters is reduced, thereby reducing platelet adhesion to vWF under high-
shear flow. This highlights its potential as an anti-thrombotic agent. 
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Legends to figures  
 
Figure 1 Platelet adhesion to vWF is inhibited by alpha-linolenic acid. EDTA-blood pre-incubated 
with vehicle or alpha-linolenic acid (ALA) for 1 hour was perfused on vWF at high-shear rate and 
platelet adhesion monitored by fluorescence microscopy. Platelet-covered area measured at the end of 
the perfusion (A) or every minute during the perfusion (B) was significantly reduced by the ALA 
treatment (n=6, p=0.0039). The first time point in B corresponds to 5 seconds after start of the flow. 
(C) Single platelet rolling velocity measurements showed an increased speed in the ALA-treated 
samples, and a correspondingly increased distance until firm adhesion (D) (n=6, p=0.04 for C and 
p=0.0009 for D). (E) representative projection images of a vehicle- or ALA-treated sample showing 
single platelets rolling over vWF. (F) Membrane cholesterol depletion by pre-incubation of EDTA-
blood with methyl-beta cyclodextrin completely abolished platelet adhesion to vWF (n=6, p<0.0001). 
Figure 2. High-shear induces vWF binding in PRP but not in washed platelets. (A) Washed 
platelets were exposed to high-shear flow and analysed for GpIb abundance by flow cytometry, 
revealing no difference between vehicle and ALA-treated platelets (n=3). MFI= mean fluorescence 
intensity. (B) PRP was either left untreated or exposed to high-shear flow, and platelet-bound vWF 
analysed by flow cytometry. In both vehicle and ALA samples, high-shear flow induced vWF 
binding, as shown by a 3-fold increase compared to unsheared samples (n=3, p<0.05). (C) Exposing 
washed platelets (WP) to high-shear flow does not lead to vWF binding; addition of exogenous 
human vWF before shear exposure results in a robust binding (n=3). 
Figure 3. High-shear induces a local rearrangement of GpIb as revealed by cryo-ET. 
Immunogold labeling (A-C) and neighborhood analysis (E-G) for the control (A, E), shear activated 
(B, F) and ALA-treated shear activated (C, G) platelets. (A-C): projection images (~70 nm in 
thickness) obtained from tomograms of platelet where GpIb alpha has been immunogold labeled. The 
labeling detection has been done with protein G conjugated to 6 nm gold (to make the gold detection 
easier, the gold has been labeled with red circles). With yellow arrows, we indicated crowded 
neighborhood occurring in the pictures. All the projections have the same scale and the scale bar in A 
is 100 nm. (E-G):  analysis of the immunogold labeling. The 3D coordinates of the 6 nm gold 
particles from 6 tomograms for each condition were selected and the distance to the “neighboring 
receptors” within a radius of 50 nm were calculated. The number of neighbors each receptor has is 
depicted in the histogram. (D): integrin αIIbβ3 immunogold labeling was performed on spread 
platelets and the same neighbouring analysis performed (H).   
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Figure 4. Comparison of GpIb labeling by super-resolution microscopy and cryo-electron 
tomography reveals a similar receptor distribution. (A) The GpIb receptors in shear-activated 
platelets were labeled and images by GSD as described in the Material and Methods. (B) In order to 
compare the localization of the receptor by cryo-ET and GSD, a synthetic model of platelet perimeter 
was generated by merging 17 tomograms from the gold-labeled platelets. The gold particle 
coordinates from the synthetic platelets where filtered to the same resolution of the GSD (20 nm), 
represented here in red. White arrowheads indicate local clustering areas. Scale bar: 2.5 μm for both 
A and B. 
Figure 5. Analysis of GpIb distribution by total internal reflection microscopy (TIRF). 
Superresolution analysis of GpIb in vehicle (A), ALA (B) or MbCD (C) platelets shows no detectable 
differences in the distribution of the receptor as measured by the particle size (D). Scale bar: 2.5 μm. 
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Supplementary Data 
Platelet isolation and cholesterol depletion 
Shearing of platelets was performed on washed platelets isolated by centrifuging platelet rich 
plasma (PRP) at 340 RCF for 10 min in the presence of 1 µM PGE1, followed by washing with 
platelet wash buffer (26 mM Na2HPO4, 140 mM NaCl, pH=7.2) and resuspension in Tyrode’s 
buffer (137 mM NaCl, 12 mM NaHCO3, 5.5 mM glucose, 2 mM KCl, 1 mM MgCl2, 2 mM 
CaCl2, 0.3 mM Na2HPO4, pH=7.4). One hundred microliters of washed platelets were 
subjected to shear stress for 1 min at a rate of 10’000 s-1 (55 dynes/cm2) in a cone-and-plate 
viscometer (CAP2000; Brookfield Inc., Middleboro, Massachusetts, USA). This shear rate has 
been shown to occur at clinically relevant 60–80% arterial stenoses1. The stainless-steel 
surfaces of the viscometer were precoated with 0.1% BSA in Tyrode’s buffer for 1 min. 
For platelet-rich plasma (PRP) isolation, blood was centrifuged at 200 RCF for 15 minutes, 
and PRP carefully removed and centrifuged again to remove contaminating leukocytes and 
erythrocytes. Cholesterol depletion of platelets was obtained by incubation of PRP with 10 mM 
methyl-beta cyclodextrin (Santa Cruz, US) at 37°C for 30 minutes. 
Platelet adhesion to vWF under high-shear flow 
Twenty-four-well plates were coated with human vWF (100 ug/ml, Hematologic Technologies 
Inc., US) for 1 hour, then washed with PBS +Ca2+ and Mg2+ and blocked with 0,1% BSA in 
PBS for 10 minutes. EDTA-anticoagulated blood was incubated with 30 µM ALA, EPA or 
stearic acid (from Cayman Chemical, US) or the same volume of vehicle (ethanol), at room 
temperature for 1 hour under gentle shaking, and platelets were concomitantly fluorescently 
labelled with calcein (4 µM final concentration, Enzo Life Science, US). Platelet adhesion was 
monitored on an inverted microscope (Leica Leitz DM IRB) with a 10x/0.22 NA objective and 
FITC filter by capturing images for 5 minutes after applying a flow of 100 dyn/cm2 to the 
blood. Platelet-covered area (fluorescent area) was calculated in the region of view with the 
Bioflux software and expressed as µm2. 
 
Immunofluorescence staining for Ground State Depletion (GSD) microscopy  
Samples were stained with a mouse anti-human GpIb-Alexa 647 antibody (MBL International, 
Woburn, US) in PBS for 2 hours at r.t., followed by 3 washes and post-fixation with 4% PFA. 
For integrin aIIbb3 staining, platelets were incubated with a mouse anti-human primary 
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antibody (Abcam, Cambridge, UK) in PBS for 1 hour at room temperature, followed by 3 
washes in PBS and a secondary antibody (donkey anti-mouse Alexa 647, Jackson 
Immunoresearch, West Grove, PA, USA) for 1 hour at room temperature2. Ground state 
depletion (GSD) and total internal reflection fluorescence (TIRF) microscopy was performed 
on a Leica SR GSD 3D microscope with a HCPL Apo 160x/1.43 NA objective. For imaging, 
samples were mounted in 200 mM phosphate buffer, pH=8.0, containing 15 mM cysteamine 
hydrochloride, 0.5 mg/ml glucose oxidase and 40 ug/ml catalase (all from Sigma-Aldrich, 
Buchs, Switzerland) as oxygen scavenging solution. We acquired 40’000 images exciting with 
a 633-nm laser and a 7.07 msec exposure; for TIRF, the penetration depth was 110 nm. Particle 
analysis in TIRF was performed with Fiji3. Alexa 647 switches reversibly between the on and 
off state, therefore, each Alexa 647 molecule might generate multiple detected events. 
Cryo-electron tomography 
Washed platelets obtained as described in “Platelet isolation” were seeded on gold grids coated 
with a Silicon mesh (R 1/4, 200 mesh, Quantifoli, Jena Germany). In case of shear activation, 
platelets were exposed to 10’000 s-1 shear rate for 1 min before being seeded. If indicated, 
platelets were treated with ALA as described above. Platelets were allowed to adhere on the 
grids for maximum 10 min and then they were fixed with 4% formaldhehyde for 5 min at room 
temperature. The time where platelets were allowed to spread on the grids was chosen based 
on a previous publication showing that GpIb clustering was stable for up to 10 minutes post-
shear4.  The EM grids were incubated in 0.05 M glycine/PBS for 15 min at room temperature 
to inactivate aldehyde groups present after fixation. Next, samples were blocked in blocking 
solution (5% BSA/0.1% cold water fish skin gelatin/PBS; Aurion) for 30 min at room 
temperature and subsequently washed 3 × 5 min with the incubation solution (0.2% BSA-
c/PBS; Aurion). Immunogold analysis was performed using anti-human GpIb antibody (6D1, 
generous gift from B. Coller, Rockefeller University NY) at a dilution of 1:100 in the 
incubation solution (0.2% BSA-c/PBS; Aurion) for 1 hour at room temperature. Next, the EM 
grids were washed 6 × 5 min at room temperature with incubation solution (0.2% BSA-c/PBS; 
Aurion) before treatment with the gold conjugate (protein G coupled to 6 nm gold; Aurion) in 
incubation solution at a dilution of 1:40 for 2 hours at room temperature. After extensive 
washing (6 × 5 min at room temperature) with the incubation solution, fiducial markers of 10 
nm were added (Aurion) and then the EM grids were plunge frozen in liquid ethane. Data 
acquisition was performed using an FEI Titan Krios transmission electron microscope 
equipped with a quantum energy filter and a K2-Summit direct electron detector (Gatan, 
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Pleasanton, USA). Tomograms were acquired with a magnification of 42,000× corresponding 
to a pixel size of 0.34 nm. The cumulative electron dose was ~80 electrons per ångström2. To 
analyze the GpIb receptor density, the 3D coordinates of the 6 nm gold were selected using the 
tom_volxyz software from the TOM toolbox software package5. We used MATLAB to search 
how many 6 nm gold particles were present in a radius of 50 nm (using the selected coordinates) 
for each of the gold particle. The amount of gold particles found with this procedure is called: 
number of neighbors. In case of the negative control, no neighbors were found (data not 
shown). The plots of the distribution for number of neighbors for each receptor and the 
statistical analysis were performed using the OriginLab software. In particular, for the peak 
analysis we used the peak Fitting tool from OriginLab. For the analysis, we used 28 tomograms 
of platelets incubated with Calcium and Magnesium-containing buffer, 11 tomograms from 
shear activated platelets, 3 tomograms from the negative control. The analysis shown in the 
paper were performed on 6 tomograms for each condition. 
Comparison between immunogold labeling and immunofluorescent data 
The comparison between the GSD and the cryo-EM data was performed described previously6. 
Briefly, 25 tomograms were projected into 2-D images and assembled such to mimic the 
membrane of a platelet. Then the xy coordinates of GpIb (6 nm gold particles) were extracted 
and represented as 2D Gaussian functions with a full width at half maximum of 20 nm using 
MATLAB. Finally, these images were colored in red using Fiji3. 
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Supplementary Figure 1 – Original cryo-ET images of the platelets displayed in Figure 2 
 
 
Figure S1. Original projection images from Fig. 2 where the 6 nm gold has not been labelled 
in red. The letter code has been kept the same. 
 
 
 
 
Supplementary Figure 2 – Synthetic platelet, before and after filtering 
 
 
 
Figure S2. Synthetic platelet model. The coordinates of the antibody labelled GpIb (6 nm gold 
particles) from 17 tomograms represented as 2D Gaussian functions with a full width at half 
maximum of 10 nm (in A) and 20 nm (in B) using MATLAB. We choose to show the image 
from B in Figure 4 in order to match the resolution for GSD. 
  
 
 
5 
Supplementary Figure 3 – Ground state depletion (GSD) microscopy on integrin aIIbb3 
 
Figure S3. Superresolution microscopy by GSD on vehicle (A) and ALA-treated (B) platelets 
shows no difference in the distribution of the integrin aIIbb3. Scale bar: 3 µm. 
 
 
 
 
 
Supplementary Figure 4 – Inhibition of platelet adhesion to vWF by the long-chain n3-FA 
eicosapentaenoic acid (EPA)  
 
 
 
Figure S4. Adhesion experiments under high-shear flow show that the marine-derived n3-FA 
EPA has a similar inhibitory effect on the platelet-covered area on vWF, whereas the saturated 
fatty acid stearic acid has no effect on platelet adhesion (n=3). 
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Supplementary video 1. Platelet adhesion to vWF under high-shear flow after treatment with 
vehicle (0.1% ethanol). 
 
Supplementary video 2. Platelet adhesion to vWF under high-shear flow after whole blood 
treatment with 30 µM alpha-linolenic acid. 
